Catalog Home Page

Pharmacogenetics of drug hypersensitivity

Phillips, E.J. and Mallal, S. (2010) Pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 11 (7). pp. 973-987.

Link to Published Version: http://dx.doi.org/10.2217/pgs.10.77
*Subscription may be required
Link to Published Version: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC293718...
*Open access, no subscription required

Abstract

Drug hypersensitivity reactions and severe cutaneous adverse drug reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, are examples of serious adverse drug reactions mediated through a combination of metabolic and immunological mechanisms that could traditionally not have been predicted based on the pharmacological characteristics of the drug alone. The discovery of new associations between these syndromes and specific HLA has created the promise that risk for these reactions could be predicted through pharmacogenetic screening, thereby avoiding serious morbidity and mortality associated with these types of drug reactions. Despite this, several hurdles exist in the translation of these associations into pharmacogenetic tests that could be routinely used in the clinical setting. HLA-B*5701 screening to prevent abacavir hypersensitivity syndrome is an example of a test now in widespread routine clinical use in the developed world.

Publication Type: Journal Article
Murdoch Affiliation: Centre for Clinical Immunology and Biomedical Statistics
Institute for Immunology and Infectious Diseases
Publisher: Ashley Publications Ltd.
Copyright: © 2010 Future Medicine Ltd
URI: http://researchrepository.murdoch.edu.au/id/eprint/2814
Item Control Page